Assessment of DNA 'fingerprinting' as a method for validating the identity of cancer cell lines maintained in long-term culture.

Por Fey, M F, Tobler, A
Publicado em 1991

Somatic rearrangement of the tropomyosin-receptor-kinase (trk) oncogene is rare in gastrointestinal cancer.

Por Fey, M. F., Thein, S. L.
Publicado em 1988

The Notch pathway in ovarian carcinomas and adenomas

Por Hopfer, O, Zwahlen, D, Fey, M F, Aebi, S
Publicado em 2005

Assessment of clonality in gastrointestinal cancer by DNA fingerprinting.

Por Fey, M F, Wells, R A, Wainscoat, J S, Thein, S L
Publicado em 1988

Clonal allele loss in gastrointestinal cancers.

Por Fey, M. F., Hesketh, C., Wainscoat, J. S., Gendler, S., Thein, S. L.
Publicado em 1989

A myeloperoxidase cDNA clone identifies an EcoRV RFLP

Por Tobler, A., Meier, R., Theilkaes, L., Viollier, A.F., Fey, M.F.
Publicado em 1990

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data

Por Bohlius, J, Tonia, T, Nüesch, E, Jüni, P, Fey, M F, Egger, M, Bernhard, J
Publicado em 2014

Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

Por Schwaller, J, Koeffler, H P, Niklaus, G, Loetscher, P, Nagel, S, Fey, M F, Tobler, A
Publicado em 1995

Up-regulation of p21WAF1 expression in myeloid cells is activated by the protein kinase C pathway.

Por Schwaller, J., Peters, U. R., Pabst, T., Niklaus, G., Macfarlane, D. E., Fey, M. F., Tobler, A.
Publicado em 1997

Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.

Por Fey, M F, Peter, H J, Hinds, H L, Zimmermann, A, Liechti-Gallati, S, Gerber, H, Studer, H, Tobler, A
Publicado em 1992

Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation

Por Schüring, A. N., Fehm, T., Behringer, K., Goeckenjan, M., Wimberger, P., Henes, M., Henes, J., Fey, M. F., von Wolff, M.
Publicado no Arch Gynecol Obstet (2017)

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies

Por Leyvraz, S, Herrmann, R, Guillou, L, Honegger, H P, Christinat, A, Fey, M F, Sessa, C, Wernli, M, Cerny, T, Dietrich, D, Pestalozzi, B
Publicado em 2006

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Por Gruber, G., Cole, B. F., Castiglione-Gertsch, M., Holmberg, S. B., Lindtner, J., Golouh, R., Collins, J., Crivellari, D., Thürlimann, B., Simoncini, E., Fey, M. F., Gelber, R. D., Coates, A. S., Price, K. N., Goldhirsch, A., Viale, G., Gusterson, B. A.
Publicado em 2008

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

Por Bernhard, J, Zahrieh, D, Coates, A S, Gelber, R D, Castiglione-Gertsch, M, Murray, E, Forbes, J F, Perey, L, Collins, J, Snyder, R, Rudenstam, C-M, Crivellari, D, Veronesi, A, Thürlimann, B, Fey, M F, Price, K N, Goldhirsch, A, Hürny, C
Publicado em 2004